Pluripotent embryonic stem cells (ESCs) have the potential to form teratomas composed of derivatives from all three germ layers in animal models. This tumorigenic potential prevents clinical translation of ESC research. In order to understand the biology and physiology of teratoma formation, we investigated the influence of undifferentiated ESC number, migration, and long-term follow up after transplantation. Murine ESCs were stably transduced with a self-inactivating (SIN) lentiviral vector with a constitutive ubiquitin promoter driving a double fusion (DF) reporter gene that consists of firefly luciferase and enhanced green fluorescent protein (Fluc-eGFP). To assess effects of cell numbers, varying numbers of ES-DF cells (1, 10, 100, 1000, and 10000) were injected subcutaneously into the dorsal regions of adult nude mice. To assess cell migration, 1x10
Ironically, the pluripotency and fast growth kinetics of ESCs also underlie their major disadvantage, as these characteristics can easily turn into undefined growth in vivo, giving rise to teratoma.
Teratoma is a complex tumor consisting of cell lines from different germ layers which are known to develop after ESC transplantation in animal models. 5, 6 Therefore, prior to future clinical translation of ESC-based therapy, basic characteristics of teratoma formation must be elucidated.
Previous studies have shown that the tumorigenic potential of ESCs seems to decrease with increasing purity of pre-differentiated target cell populations, such as cardiomyocytes 7 or oligodendrocyte progenitor cells. 3 However, the maximum number of contaminant undifferentiated ESCs in these pre-differentiated populations for safe non-tumorigenic application remains unknown. Secondly, it has been shown recently that the tumorigenic potential of ESCs is dependent upon the site of transplantation. 8 Whether it is also possible that transplanted
ESCs can form teratoma in distant graft sites need to be examined. Lastly, as teratoma formation usually presents around two to four weeks after transplantation 2, 8 , the long-term fate of transplanted, undifferentiated cells has never been investigated. By studying these issues, this study aims to evaluate the in vivo tumorigenic characteristics of ESCs.
methodS

Culture of undifferentiated ESCs. The murine ES-D3 cell line was derived originally from
Sv129 mice and obtained commercially from ATCC (Manassas, VA). Undifferentiated cells were maintained with 1000 IU/mL leukemia inhibitory factor (Chemicon, ESGRO, ESG1107) and murine embryonic fibroblasts (MEFs) feeder layer inactivated by 10 ug/mL mitomycin C (Sigma).
Murine ESCs were cultured on 0.1% gelatin-coated plastic dishes in ES medium containing Dulbecco Modified Eagle Medium (DMEM) supplemented with 15% fetal calf serum, 0.1 mmol/L β-mercaptoethanol, 2 mmol/L glutamine, and 0.1 mmol/L nonessential amino acids (Gibco) as described previously. 9 Culture medium was changed every day. Murine ESCs were passaged every 1 or 2 days. Images were obtained using a ZEISS Axiovert microscropy (Sutter Instrument). Explanted subcutaneous teratomas were routinely processed for hematoxylin and eosin (H&E).
Slides were interpreted by an expert pathologist (A.J.C) blinded to the study.
Data analysis.
Data are given as mean ± SD. For statistical analysis, the two-tailed Student's t-test was used. Differences were considered significant at P<0.05. showed no significant differences in proliferation rate (P=NS) (figure 1d). Taken together, these data suggest that lentiviral transduction is a robust method to introduce reporter genes into ESCs without significantly affecting their self-renewal and pluripotency characteristics. Minimal number of undifferentiated murine ESCs causing teratoma formation. At present, it is not feasible to select or grow 100% pure ESC-derived progenitor cells. 13, 14 Thus, it is likely that at the time of therapeutic transplantation, mixed cell populations may still contain some undifferentiated ESCs. Therefore, we set out to determine the lowest threshold of undifferentiated ESC contaminant that can still cause teratoma formation. In order to do so, we first investigated the minimal reproducible cell number that can be imaged in vitro. The results from in vitro BLI indicated that 10,000 ES-DF cells were easily noticeable (figure 2a). Marginal signal from 1000 ES-DF cells led us to hypothesize that it is possible to image as low as 500 to 1000 cells in vivo if they are located within a compact region. Indeed, 7 days after subcutaneous transplantation of 500 to 1000 ES-DF cells, which were kept localized to the same region ESC survival and migration after intramyocardial injection. Previous studies have shown that transplantation of undifferentiated murine ESCs into immunodeficient mice leads to teratoma formation using conventional histological techniques. 15 delivery, a strong BLI signal was present within the chest region. Moreover, a separate focal signal within the long femur bone marrow was noticeable, which is likely due to leakage from the intramyocardial injection and seeding peripherally. At day 35, all mice were too weak for further follow-up and had to be euthanized. During necropsy, the organs were explanted and imaged immediately. Ex vivo bioluminescence signals were found in the heart, spine, humerus, femur, submandible (figure 3b).
ReSultS
Lentiviral transduction and characterization of murine ES
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Animals injected with control non-transduced ESCs showed no bioluminescence signals as expected (data not shown). Finally, histological examination with H&E staining also confirmed presence of teratoma formation in the heart, femur, and submandible ( figure 4) . Interestingly, only a small amount of intramyocardially transplanted ES-DF cells expressed the cardiac-specific marker troponin T, suggesting that the in vivo differentiation of ESCs into cardiomyocytes also occurred at a low frequency (figure 4a). Long-term tracking of ESC fate by BLI. In order to investigate whether lower cell number would have a different outcome, we decided to inject a smaller number (∼10,000) of ES-DF cells and follow the animals for a longer period. Since the smaller size of mice was only able to bear teratoma formation for up to 5 weeks, we switched to the larger size rats. This also allowed us to test the influence of different animal species. After intramyocardial injection of 10,000 ES-DF cells, nude rats were followed by BLI longitudinally (figure 5a, 5b). After 10 months, animals were sacrificed and hearts were explanted for visual inspection of gross morphology. Histological sectioning of all hearts confirmed differentiation into all three germ layers (figure 5c).
These results indicate that, even after deliberate local delivery into the left ventricular mass, the process is still associated with extra-cardiac leakage and seeding to other organs. 
diSCuSSion
ESCs hold great promise in regenerative medicine. However, several critical obstacles need to be resolved before ESCs can play a role in clinical medicine. Among these are the immunogenicity of ESCs, and perhaps more importantly from the safety standpoint, the tumorigenic ability of ESCs. 6, 16 This study has shown that molecular imaging is a reliable tool for long-term in vivo imaging of ESCs. Our major findings are as follows: (a) reporter genes do not affect ES cell viability and proliferation; (b) as low as 500-1000 undifferentiated ESCs are capable of inducing teratoma formation; and (c) ESCs are capable of causing teratomas in both intra-cardiac and extra-cardiac sites after local intramyocardial delivery.
Although the risk of teratoma formation may be reduced by prolonged cell differentiation before its engraftment, in reality pre-differentiated ESCs or ESC-derived precursor cells might still form teratoma after transplantation into animals. 17 Recently, Harkany et al. observed teratoma formation after transplantation of 400 murine ESCs in the brain of naive mice. 18 Here we pre-
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sent further evidence that even 500 to 1000 murine ESCs were sufficient to induce teratoma formation, while less than 100 ESCs were not. In contrast, Nussbaum et al. have shown that 50,000 intramyocardially injected murine ESCs were not noticeable in the heart and spleen and did not form teratoma after 3 weeks. 16 Several factors might underlie the discrepancy between the findings. First of all, to mimic cell contamination, we have transplanted different numbers of ESCs accompanied by MEFs to achieve a total cell number of 100,000 cells. The MEFs might have contributed to better ESC engraftment, survival, and subsequent teratoma formation. Secondly, using conventional histological staining, Nussbaum et al. investigated teratoma formation at the site of transplantation (myocardium) and at one distant location (spleen), with both locations free of ESCs. 16 This was in concordance with a recent report, whereby teratomas were induced in the kidney capsule of immunodeficient mice but without any human ESC activity in the spleen after 8 weeks as well. 19 By contrast, using more sensitive in vivo whole body molecular imaging, which was validated by immediate ex vivo imaging of explanted organs, we did observe profound activity at other distant locations, such as the submandible and femur, suggesting ESC leakage during transplantation and subsequent engraftment and proliferation into teratoma. Taken together, these findings suggest longitudinal noninvasive imaging may
give more valuable insight into teratoma formation and migration compared to conventional histology.
Previously, we had demonstrated the feasibility of using triple fusion reporter gene to track the fate of transplanted murine ESCs in living subjects by fluorescence, bioluminescence and positron emission tomography (PET) modalities. 2 This was followed by another study showing that not only does the herpes simplex virus thymidine kinase (HSV-tk) PET reporter gene can be used to monitor ESC engraftment, it also serves useful purpose as a suicide gene to ablate ESC misbehavior. 20 In the current study, we further expanded on these initial observations by using a SIN lentiviral vector with ubiquitin promoter driving the bioluminescence (Fluc) and fluorescence (eGFP) to address the influence of undifferentiated ESC number, migration, and long-term follow up after transplantation. The human immunodeficiency virus type 1 (HIV-1)-based lentiviral vector has been shown to be an excellent tool for stable and efficient gene transfer to mouse 21 and human ESCs. 22 The enhanced safety of the self-inactivating (SIN) lentivirus is achieved by (a) using a three-plasmid expression system which consists of packaging, envelop, and vector constructs light. The variant eGFP has a shifted excitation spectrum to longer wavelength (488 nm) and has increased brightness (35-fold). 25 Thus, by using the double fusion reporter gene construct, we were able to perform FACS to isolate stably transduced ESCs (via eGFP) and track their fate in living animals (via Fluc) at a rapid and high-throughput fashion. 26 In this study, we were able to reliably monitor the fate of 10,000 transplanted ESCs in the heart for a period as long as 10 months in living animals. The clinical relevance of these findings is profound. As an example, current clinical trials involving bone marrow stem cells for the infarcted heart report injecting a mean cell number of 6.8x10 7 , there is a lack of comparison studies on teratoma formation. In the future, the same issue of minimal human ESCs that can cause teratoma formation will need to be addressed.
Second, ESCs tend to differentiate at an earlier stage when implanted subcutaneously (compared to intra-hepatic transplantation) as described by Cooke and colleagues 8 . In this respect, the well vascularized, growth factor-rich, and perhaps immune-privileged porous structure in the liver may help to maintain ESCs in undifferentiated state. 8 Thus, it is plausible that when transplanted in the liver, the minimal cell number needed for teratoma formation might be even lower than the 500 to 1,000 cells found on subcutaneous study in the present study. Third, we used nude mice while others have relied on severe combined immunodeficient (SCID) mice.
Nude mice (lacking furs) are easier to image but have more natural killer (NK) cell activity as compared to SCID mice 32 , which could also contribute to transplanted cell death by NK cellmediated cytotoxicity. 33 Moreover, decreased tumor engraftment and higher regression rates of several tumor cell lines have been observed in nude mice as compared to increased tumor growth and larger tumor mass in SCID mice. 34, 35 These observations suggest that the actual cell number needed for teratoma formation could be even lower in the case of SCID mice.
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In summary, we have provided important insight into the influence of ESC number, cell migration, and engraftment period on teratoma formation. These findings are an additional stimulus for further research on this topic. Therefore, our ongoing work is focusing on optimizing in vitro differentiating systems to acquire purer populations for transplantation, in vivo imaging of stem cell behavior, and how to control teratoma formation after transplantation. All these issues need thorough understanding in order for ESCs to play the prominent role they are expected to play in clinical treatments.
